Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 104.6 CHF 14.44%
Market Cap: 1.8B CHF

Intrinsic Value

The intrinsic value of one COPN stock under the Base Case scenario is hidden CHF. Compared to the current market price of 104.6 CHF, Cosmo Pharmaceuticals NV is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

COPN Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Cosmo Pharmaceuticals NV

Intrinsic Value History
Dive into the past to invest in the future

COPN looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether COPN usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about COPN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is COPN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cosmo Pharmaceuticals NV.

Explain Valuation
Compare COPN to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about COPN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cosmo Pharmaceuticals NV

Current Assets 202.3m
Cash & Short-Term Investments 143m
Receivables 45.8m
Other Current Assets 13.5m
Non-Current Assets 444.5m
Long-Term Investments 31.8m
PP&E 29.1m
Intangibles 355.9m
Other Non-Current Assets 27.7m
Current Liabilities 48.3m
Accounts Payable 10.6m
Accrued Liabilities 2.6m
Other Current Liabilities 35.1m
Non-Current Liabilities 100.2m
Long-Term Debt 1.4m
Other Non-Current Liabilities 98.8m
Efficiency

Free Cash Flow Analysis
Cosmo Pharmaceuticals NV

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cosmo Pharmaceuticals NV

Revenue
182.3m EUR
Cost of Revenue
-47.8m EUR
Gross Profit
134.5m EUR
Operating Expenses
-74m EUR
Operating Income
60.5m EUR
Other Expenses
-5.3m EUR
Net Income
55.2m EUR
Fundamental Scores

COPN Profitability Score
Profitability Due Diligence

Cosmo Pharmaceuticals NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Operating Margin
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Exceptional Net Margin
hidden
Profitability
Score

Cosmo Pharmaceuticals NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.

COPN Solvency Score
Solvency Due Diligence

Cosmo Pharmaceuticals NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Cosmo Pharmaceuticals NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

COPN Price Targets Summary
Cosmo Pharmaceuticals NV

Wall Street analysts forecast COPN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COPN is 105.83 CHF with a low forecast of 82.82 CHF and a high forecast of 136.5 CHF.

Lowest
Price Target
82.82 CHF
21% Downside
Average
Price Target
105.83 CHF
1% Upside
Highest
Price Target
136.5 CHF
30% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for COPN is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

COPN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one COPN stock?

The intrinsic value of one COPN stock under the Base Case scenario is hidden CHF.

Is COPN stock undervalued or overvalued?

Compared to the current market price of 104.6 CHF, Cosmo Pharmaceuticals NV is hidden .

Back to Top